Verve Therapeutics Inc.

6.41
0.08 (1.26%)
At close: Mar 03, 2025, 12:41 PM

Verve Therapeutics Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for VERV stock have an median target of 24.5, with a low estimate of 15 and a high estimate of 40. The median target predicts an increase of 282.22% from the current stock price of 6.41.

Target Low Average Median High
Price $15 $26 $24.5 $40
Change 134.01% 305.62% 282.22% 524.02%

AI Analyst Report

HC Wainwright & Co. retains a Buy rating on Verve ... Unlock content with Pro Subscription

Updated Feb 28, 2025

Rating Apr 24May 24Aug 24Nov 24Feb 25
Strong Buy 00011
Buy 11320
Hold 00000
Sell 00000
Strong Sell 00000
Total 1 1 3 3 1

Financial Forecast this Year

Revenue This Year
22.84M
from 32.33M
Increased by -29.4%
Revenue Next Year
16.33M
from 22.84M
Increased by -28.5%
EPS This Year
-2.66
from -2.36
Increased by -12.7%
EPS Next Year
-2.63
from -2.66
Increased by 1.1%